Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia

por Sarapura Martinez, Valeria J., Buonincontro, Brenda, Cassarino, Chiara, Bernatowiez, Juliana, Colado, Ana, Cordini, Gregorio, Custidiano, Maria del Rosario, Mahuad, Carolina, Pavlovsky, Miguel A., Bezares, Raimundo F., Favale, Nicolás O., Vermeulen, Mónica, Borge, Mercedes, Giordano, Mirta, Gamberale, Romina
Publicado 2023

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic...

por Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela, Cramer, Paula
Publicado 2020